MGO One Seven’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.22M Buy
35,611
+5,625
+19% +$471K 0.05% 363
2026
Q1
$2.4M Buy
29,986
+5,471
+22% +$451K 0.05% 405
2025
Q4
$2.09M Buy
24,515
+5,571
+29% +$457K 0.04% 432
2025
Q3
$1.47M Buy
18,944
+11,678
+161% +$912K 0.03% 480
2025
Q2
$568K Buy
7,266
+604
+9% +$45K 0.02% 682
2025
Q1
$483K Buy
6,662
+4
+0.1% +$286 0.02% 642
2024
Q4
$493K Buy
6,658
+931
+16% +$65.2K 0.02% 625
2024
Q3
$378K Buy
5,727
+65
+1% +$4.72K 0.02% 681
2024
Q2
$523K Buy
5,662
+395
+7% +$35K 0.02% 538
2024
Q1
$503K Sell
5,267
-668
-11% -$56.1K 0.03% 515
2023
Q4
$453K Buy
5,935
+1,246
+27% +$86.7K 0.03% 564
2023
Q3
$325K Sell
4,689
-50
-1% -$4.02K 0.03% 587
2023
Q2
$447K Sell
4,739
-815
-15% -$70.8K 0.04% 450
2023
Q1
$460K Buy
5,554
+885
+19% +$69.6K 0.03% 505
2022
Q4
$348K Sell
4,669
-114
-2% -$8.79K 0.03% 506
2022
Q3
$395 Sell
4,783
-168
-3% -$16.2K 0.02% 451
2022
Q2
$471K Sell
4,951
-15,850
-76% -$1.64M 0.07% 333
2022
Q1
$2.45M Buy
20,801
+4,160
+25% +$467K 0.26% 93
2021
Q4
$2.16M Buy
16,641
+3,360
+25% +$392K 0.22% 111
2021
Q3
$1.59M Buy
13,281
+1,197
+10% +$137K 0.2% 132
2021
Q2
$1.25M Buy
12,084
+6,972
+136% +$657K 0.18% 152
2021
Q1
$427K Buy
+5,112
New +$432K 0.07% 329
2019
Q1
Sell
-654
Closed -$33K 775
2018
Q4
$33K Buy
+654
New +$33.1K 0.01% 755
2018
Q1
$36K Hold
774
0.02% 691
2017
Q4
$29K Buy
+774
New +$28.4K 0.01% 761

Other funds holding EW

MGO One Seven's EW Position: Q2 2026 in Review

MGO One Seven increased its Edwards Lifesciences (EW) stake by 19% in Q2 2026, buying an estimated $471K and bringing the position to 35,611 shares worth $3.22M. The position accounts for 0.05% of the portfolio, ranked #363.

MGO One Seven first reported a position in EW in Q4 2017 and has held it in 25 quarters since. 1,327 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • MGO One Seven held 35,611 shares of Edwards Lifesciences worth $3.22M as of Q2 2026.
  • MGO One Seven bought 5,625 Edwards Lifesciences shares in Q2 2026, an estimated $471K.
  • Edwards Lifesciences made up 0.05% of MGO One Seven's portfolio in Q2 2026, its #363 holding.
  • MGO One Seven first reported a position in Edwards Lifesciences in Q4 2017 and has held it in 25 quarters since.
  • 1,327 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on MGO One Seven's 13F filing for Q2 2026, filed 31 Jul 2026.